Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Klinisk Tandteknik Troels Renard Aps Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   4.0% 3.0% 3.0% 2.0% 1.3% 1.6% 9.0% 9.0%   Credit score (0-100)   51 59 57 68 80 74 27 27   Credit rating   BBB BBB BBB A A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.3 38.4 6.8 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   899 1,057 789 1,886 2,197 2,434 0.0 0.0   EBITDA   190 254 191 785 825 657 0.0 0.0   EBIT   190 254 191 785 825 657 0.0 0.0   Pre-tax profit (PTP)   189.0 253.2 186.0 774.4 776.3 565.2 0.0 0.0   Net earnings   147.4 197.5 145.1 604.1 661.0 427.7 0.0 0.0   Pre-tax profit without non-rec. items   189 253 186 774 776 565 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   27.3 18.2 67.5 3,564 3,548 3,597 0.0 0.0   Shareholders equity total   313 510 434 1,038 1,699 2,127 2,077 2,077   Interest-bearing liabilities   0.0 0.0 0.0 1,782 1,712 1,660 0.0 0.0   Balance sheet total (assets)   562 630 532 4,528 3,960 4,071 2,077 2,077   Net Debt   -176 -299 -182 1,678 1,600 1,586 -2,077 -2,077     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   899 1,057 789 1,886 2,197 2,434 0.0 0.0   Gross profit growth   -0.8% 17.5% -25.3% 139.0% 16.5% 10.8% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   562 630 532 4,528 3,960 4,071 2,077 2,077   Balance sheet change%   39.9% 12.1% -15.5% 751.0% -12.5% 2.8% -49.0% 0.0%   Added value   189.7 253.9 191.2 785.2 824.9 657.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -9 -9 49 3,496 -16 49 -3,597 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   21.1% 24.0% 24.2% 41.6% 37.6% 27.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   39.4% 42.6% 32.9% 31.0% 19.4% 16.4% 0.0% 0.0%   ROI %   76.8% 61.7% 40.5% 48.3% 26.5% 18.3% 0.0% 0.0%   ROE %   61.7% 48.0% 30.7% 82.0% 48.3% 22.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   55.7% 81.0% 81.6% 22.9% 42.9% 52.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -92.7% -117.6% -95.0% 213.7% 194.0% 241.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 171.6% 100.7% 78.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.0% 0.0% 0.0% 1.2% 2.8% 5.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.0 4.8 3.8 0.2 0.1 0.0 0.0 0.0   Current Ratio   2.1 4.9 3.9 0.3 0.1 0.0 0.0 0.0   Cash and cash equivalent   175.9 298.6 181.6 104.0 111.3 73.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   261.4 468.0 282.1 -2,609.8 -2,116.9 -1,722.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0